Clinical Trial Update: Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness of a Mepivacaine-Tramadol combination for the success of inferior alveolar nerve block in symptomatic irreversible pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Mepivacaine (mepivacaine)
• Tramadol (tramadol)

Snippet

Sponsor: Daniel Chavarría Bolaños | Conditions: Symptomatic Irreversible Pulpitis | Phase 4 | Status: COMPLETED